SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Advanomics Corporation, the Parent Company of Sunshine Biopharma, Inc., Files a New Patent Application for Its Multidrug Resistance Adva-27a Anticancer Compound